We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AstraZeneca is buying TBio subsidiary TeneoTwo, which will shore up its hematology pipeline with TeneoTwo’s candidate for relapsed and refractory B-cell non-Hodgkin lymphoma. Read More
Novartis said it has resumed operations at its Millburn, N.J., and Ivrea, Italy, plants after recently halting production over quality lapses related to the manufacture of radioligand therapy medicines. Read More
Sanofi will begin offering 30-day supplies of its insulin products to uninsured patients in the U.S. for $35 on July 1, the company announced Wednesday. Read More
Molecure said it is considering going back to its original plan, which was to develop OATD-01 for treatment of the inflammatory disease sarcoidosis. Read More
Moderna is also collaborating with the UK’s National Institute for Health Research on a phase 3 study investigating the company’s bivalent Omicron-containing booster candidate. Read More